Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now later-stage tilt small index

Burn: later-stage trial registry

5 of 9 indexed Burn trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Burn: 9 US clinical trials tracked, 5 recruiting.

Burn is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Medstar Health Research Institute, running 2 of these trials.

Enrollment posture brief

Registry condition burn

OPEN 5 | RECR 56% | LATE 3 | EARLY 0 | RANK #1916 | SPON 2

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Burn (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Burn

Burn lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Burn on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Burn is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Burn research.

    Medstar Health Research Institute accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Burn trials plan to enrol fewer than 100 people.

    Median target enrolment is 34 among the 9 trials that report a genuine target (sentinel values excluded). 8 of those (88.9%) plan for fewer than 100 participants.

  4. Burn research is mostly interventional.

    7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 43

Phase Distribution

PhaseTrial count
Phase 4 3

Named interventions

Most-linked intervention names on Burn records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Control standard nurse wound care Behavioral
1 trials
Virtual Reality slides of nature Behavioral
1 trials
Virtual Reality Snowworld Behavioral
1 trials
silver sulfadiazine Drug
1 trials
water-soluble therapy Drug
1 trials
Cohealyx Device
1 trials
0.9% NaCl Drug
1 trials
Standard Progressive Muscle Relaxation Behavioral
1 trials

US sites by state

Facility locations filed on Burn trials. A trial with sites in several states counts in each.

Washington 2 trials
Virginia 2 trials
Texas 1 trials
Tennessee 1 trials
South Carolina 1 trials
Ohio 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Burn page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Burn condition card totals 9 registered trials; most-linked intervention Control standard nurse wound care; top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.